Navigation Links
Lorus in Medical News

AMEX Accepts Lorus' Plan to Meet AMEX's Continued Listing Standards

... TORONTO, May 6 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus" or the "Company") (TSX:...y the end of the extension period. About Lorus lorus is a biopharmaceutical company focused on the rese...forts and an acquisition and in-licensing program, lorus is building a portfolio of promising anticancer dr...

Lorus announces presentation of corporate overview at the Rodman and Renshaw Annual Healthcare Conference

...b cast- TORONTO, Nov. 6 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ('Lorus'), a biopharmaceutical c...ies for healthcare companies and investors. About lorus lorus is a biopharmaceutical company focused on the rese...

Lorus Therapeutics announces election of three new Directors and appoints a new Chairman

... TORONTO, Sept. 19 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR; AMEX: LRP), a biophar...lified individuals to our Board. They all bring to lorus an exceptional level of knowledge and experience i...g with them, to enhance shareholder value." About lorus ...
Lorus in Medical Technology

Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Conference

...e presented on April 17, 2007. In this research, lorus screened a series of siRNAs to select a lead drug ... development of siRNA-1284 as an anticancer agent. lorus is also pursuing other cancer targets with its siR...r drug discovery and medical therapeutics. About lorus ...
Lorus in Biological Technology

Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008

... TORONTO, July 21 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (Lorus), a biopharmaceutical com...Phase I clinical study in cancer indications. lorus intends to submit an IND for LOR-253 by the Q...srael. Under the terms of the licensing agreement, lorus is entitled to receive payments in excess of ...

Lorus Therapeutics Receives $600 Thousand From Escrow Account

... TORONTO, July 16 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" or the "Corporation"), a b...ce on forward-looking statements due to the inherent uncertainty therein. lorus Therapeutics Inc.'s recent press releases are available through the Company...

Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program

... TORONTO, July 9 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" o...tected in Mexico under an earlier patent issued to lorus in 2003. Virulizin(R) has demonstrated significa...locally advanced and metastatic pancreatic cancer. lorus has reported that the overall survival data in thi...

Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)

...ivity - TORONTO, July 2 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" o...te (NCI) Cancer Therapy Evaluation Program (CTEP). lorus is collaborating with the Division of Cancer Treat...r growth and metastatic potential. About Lorus lorus is a biopharmaceutical company focused on the rese...

Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions

... TORONTO, May 5 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP),...Lorus' senior management team. Dr. Babaei joined lorus in 2006, where he has held the progressive positio...-for-profit organizations. Dr. Lee has been with lorus for ten years, most recently serving as the Direct...

Lorus initiates development program exploring novel route of administration for LOR-2040

... TORONTO, April 22 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ('Lorus'), a biopharmaceutical c...se of LOR-2040 in the treatment of bladder cancer. lorus intends to submit the IND during Q3, 2008, followi...r growth and metastatic potential. About Lorus lorus is a biopharmaceutical company focused on the rese...

Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040

...CR) - TORONTO, April 16 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP),...esented on April 16, 2008. In this presentation, lorus provided data on the preclinical development of LO...nked to the development of cancer. About Lorus lorus is a biopharmaceutical company focused on the rese...

Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)

...ales - TORONTO, April 8 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP),...ated Asher Nathan, Managing Director of Zoticon. lorus invites analysts and media to participate in a con... Virulizin(R) is a registered trademark owned by lorus Therapeutics Inc. About...

Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer

... TORONTO, Jan. 22 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. (TSX: LOR; AMEX: LRP), a biophar...rofessional skills and integrity." About Lorus lorus is a biopharmaceutical company focused on the rese...forts and an acquisition and in-licensing program, lorus is building a portfolio of promising anticancer dr...

Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia

... TRIAL TORONTO, Aug. 29 /PRNewswire-FirstCall/ - lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP),...fficacy evaluation in a larger patient population. lorus expects the clinical trial to be completed by the end of 2008. The decision by lorus to advance clinical development of GTI-2040 is bas...
Other Tags
(Date:8/22/2014)... Washington, DC (PRWEB) August 22, 2014 ... a little easier in the coming year for four ... from the National League for Nursing Foundation for ... candidates – will share $28,000, $10,000 more than in ... Margaret Ann Kerr Endowment and Elizabeth Isaac Marcil Endowment ...
(Date:8/22/2014)... Vegas, NV (PRWEB) August 22, 2014 ... by Dr. Sen and Dr. Samantha Pearson to help ... contacts, and avoid corrective vision surgery by instead improving ... Michaels, prompting an investigative review. , “There’s a ... of dollars in revenue each year—it’s because people just ...
(Date:8/22/2014)... August 22, 2014 Advancements in ... some clinical applications due to their cost-effectiveness, non-invasiveness, ... innovations in ultrasound, such as the evolution of ... to keep the market moving throughout 2014 and ... can enhance not only the point-of-care (POC) testing ...
(Date:8/22/2014)... New York, New York (PRWEB) August 22, 2014 ... ) continue to be filed in U.S. courts ... cardiovascular events due to their use of prescription ... to court documents, a new claim was filed ... California man who allegedly suffered life-threatening heart issues ...
(Date:8/22/2014)... Eagerly embracing intended parents around the ... now offers the top male infertility programs — run ... fertility network of IVFinMexico.com continues to shape ... care, female and male infertility, advanced research and education. ... so eminently set by company CEO and Founder Tolga ...
Breaking Medicine News(10 mins):Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 4
(Date:8/21/2014)... 18-22, 2014 , WHERE: , San Diego ... CA 92101 , WHAT: , Invited and ... latest research in human genetics. Examples of sessions ... on rare genetic variants in health and disease, ... sun sensitivity (Saturday, Oct. 18, 5:30-7:30 pm) , ...
(Date:8/21/2014)... tube connectors, designed by an international standards process, will ... According to an invited review published in the OnlineFirst ... NCP ), the official journal of the American Society ... will greatly reduce the occurrence of misconnection that can ... connectors, which are used to join medical devices, components, ...
(Date:8/21/2014)... has successfully replicated one of the crucial steps in ... sunlight which could manufacture hydrogen as a fuel. , ... an exciting prospect to use them to create hydrogen, ... Hingorani, from the ARC Centre of Excellence for Translational ... Hydrogen offers potential as a zero-carbon replacement for petroleum ...
Breaking Biology News(10 mins):American Society of Human Genetics 2014 Annual Meeting 2New feeding tube connectors will improve patient safety 2Water and sunlight the formula for sustainable fuel 2
Other Contents